Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $666M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 319,773 | $46.05M | 6.9% | $48.11 | +154.6% | COM PAR $.01 | 457669307 |
| MIRM | MIRUM PHARMACEUTICALS INC | 570,569 | $41.83M | 6.3% | $33.08 | +92.2% | COM | 604749101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 85,318 | $35.77M | 5.4% | $336.31 | 0.0% | COM | 91307C102 |
| — | MERUS N V | 372,022 | $35.03M | 5.3% | $61.42 | — | COM | N5749R100 |
| NUVL | NUVALENT INC | 394,754 | $34.14M | 5.1% | $71.10 | +11.2% | COM | 670703107 |
| XENE | XENON PHARMACEUTICALS INC | 799,743 | $32.11M | 4.8% | $37.92 | -7.1% | COM | 98420N105 |
| BBIO | BRIDGEBIO PHARMA INC | 589,729 | $30.63M | 4.6% | $29.85 | +63.4% | COM | 10806X102 |
| RVMD | REVOLUTION MEDICINES INC | 643,050 | $30.03M | 4.5% | $45.05 | -13.1% | COM | 76155X100 |
| ASND | ASCENDIS PHARMA A/S | 146,291 | $29.08M | 4.4% | $144.94 | — | SPONSORED ADR | 04351P101 |
| ARGX | ARGENX SE | 38,767 | $28.59M | 4.3% | $388.36 | — | SPONSORED ADR | 04016X101 |
| IRON | DISC MEDICINE INC | 397,693 | $26.28M | 3.9% | $50.06 | +18.8% | COM | 254604101 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,159,474 | $25.91M | 3.9% | $10.42 | +1.0% | COM | 68622P109 |
| ACLX | ARCELLX INC | 313,733 | $25.76M | 3.9% | $65.31 | +10.2% | COMMON STOCK | 03940C100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 181,897 | $25.53M | 3.8% | $135.50 | 0.0% | COM | 64125C109 |
| ABVX | ABIVAX SA | 291,820 | $24.78M | 3.7% | $84.90 | — | SPONSORED ADS | 00370M103 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 716,971 | $20.39M | 3.1% | $19.81 | +21.0% | ORDINARY SHARES | N62509109 |
| — | AKERO THERAPEUTICS INC | 397,010 | $18.85M | 2.8% | $49.18 | — | COM | 00973Y108 |
| AXSM | AXSOME THERAPEUTICS INC | 152,614 | $18.53M | 2.8% | $77.83 | +44.7% | COM | 05464T104 |
| ELVN | ENLIVEN THERAPEUTICS INC | 783,411 | $16.04M | 2.4% | $21.05 | -4.2% | COM | 29337E102 |
| APGE | APOGEE THERAPEUTICS INC | 402,811 | $16M | 2.4% | $45.46 | -16.0% | COM | 03770N101 |
| KYMR | KYMERA THERAPEUTICS INC | 277,726 | $15.72M | 2.4% | $45.10 | 0.0% | COM | 501575104 |
| JANX | JANUX THERAPEUTICS INC | 639,699 | $15.63M | 2.3% | $42.49 | -42.7% | COM | 47103J105 |
| ROIV | ROIVANT SCIENCES LTD | 959,703 | $14.52M | 2.2% | $12.38 | 0.0% | SHS | G76279101 |
| CYTK | CYTOKINETICS INC | 254,795 | $14M | 2.1% | $41.20 | 0.0% | COM NEW | 23282W605 |
| NTRA | NATERA INC | 80,875 | $13.02M | 2.0% | $128.20 | +23.4% | COM | 632307104 |
| ADMA | ADMA BIOLOGICS INC | 808,673 | $11.86M | 1.8% | $17.93 | -4.4% | COM | 000899104 |
| VERA | VERA THERAPEUTICS INC | 354,529 | $10.3M | 1.5% | $35.85 | -35.5% | CL A | 92337R101 |
| HROW | HARROW INC | 160,234 | $7.72M | 1.2% | $32.60 | +15.6% | COM | 415858109 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 262,643 | $1.883M | 0.3% | $52.12 | 0.0% | CLASS A ORD | 61559X104 |